COPD Prognosis in Covid Patients

March 9, 2022 updated by: Islam Mokhtar Ahmed, Sohag University

Chronic Obstructive Pulmonary Disease Prognosis in Sars-covid 2 Infection

In this prospective observational study, patients were selected from attendees of the intensive care unit. Different measures and outcomes had been studied and compared between patients with and without COPD, including hospitalization, medical costs, length of Intensive care stay, respiratory failure, and death rate.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sohag, Egypt
        • Faculty of Medicine, Sohag University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

male or female patient more than 20 years old, recently diagnosed covid positive

Description

Inclusion Criteria:

  • Age: more than 20 years old.

    • Both Males and females will be included.
    • COPD patients.
    • Recent confirmed the diagnosis with SARS-COV-2.

Exclusion Criteria:

  • Pregnancy.

    • Malignancy.
    • Immunodeficiency disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
copd patients with covid infection
patients who were in need were intubated and mechanically ventilated
non-copd patients with covid infection
patients who were in need were intubated and mechanically ventilated

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SOFA score measurement in both groups
Time Frame: 2 weeks
monitoring of SOFA items along two weeks
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
prognosis of the disease
Time Frame: 2 weeks
hospital stay, nedd for mechanical ventilation
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2021

Primary Completion (Actual)

December 1, 2021

Study Completion (Actual)

January 1, 2022

Study Registration Dates

First Submitted

March 5, 2022

First Submitted That Met QC Criteria

March 9, 2022

First Posted (Actual)

March 10, 2022

Study Record Updates

Last Update Posted (Actual)

March 10, 2022

Last Update Submitted That Met QC Criteria

March 9, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • soh-Med-22-1-26

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Failure

Clinical Trials on intubation and mechanical ventilation

3
Subscribe